Vitality Watch

Dossier pubmed preclinical 08-jul-2026
Animal model, organoid, or cell-culture result — not yet human

Immune dysregulation in the prostates of C57BL/6mice mirrors that seen in human benign prostatic hyperplasia.

Key claim: A chronic nonresolving inflammation model in C57BL/6 mice produces prostatic immune dysregulation—including Trem2 macrophages, aging-associated CD8 GZMK-hi T cells, and aging-marker fibroblasts—that mirrors patterns seen in human benign prostatic hyperplasia.

Abstract

Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging men, resulting in significant morbidity. The etiologies of BPH are unknown, though chronic prostatic inflammation is known to promote hyperplasia, fibrotic remodeling, and therapeutic resistance in BPH. BPH is highly complex and heterogeneous, presenting with varying degrees of stromal and epithelial proliferation, fibrosis, inflammation, and associated lower urinary tract symptoms. This complexity poses challenges in developing models. Here, we characterize an Aire transcription factor-deficient nonresolving (chronic) inflammation model in a C57BL/6J background for the study of the prostatic inflammation present in BPH. This chronic inflammatory model exhibits a lack of central tolerance but retains an otherwise intact and functional immune system. C57BL/6mice were subcutaneously injected with prostate homogenate protein and Freund’s Complete Adjuvant and boosted after 10 days. After 21 and 35 days, whole prostates were collected for histology, flow cytometry, and single-cell RNA sequencing (scRNA-seq), which were then compared to human BPH data. Inflammation was confined to the prostate in C57BL/6mice. Histological and scRNA-seq data show that the dominant leukocyte phenotypes in the prostates of C57BL/6mice are B and T lymphocytes. Macrophages in C57BL/6mouse prostates express signatures associated with an array of phenotypes, as also seen in BPH. We identify a Trem2population of macrophages and aging-associated Cd8GZMK hi GZMB low T cells in C57BL/6prostates similar to those seen in human BPH. Further, fibroblast clusters in C57BL/6are similar to fibroblasts identified from the prostates of patients diagnosed with BPH, and these clusters also express markers associated with aging. Overall, the inflammation and predicted leukocyte–stromal interactions observed in the prostates of C57BL/6mice resemble human BPH, likely at the early stages of the disease, making this model useful for studying the impact of inflammation-driven prostatic hyperplasia. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Why this matters

A chronic nonresolving inflammation model in C57BL/6 mice produces prostatic immune dysregulation—including Trem2 macrophages, aging-associated CD8 GZMK-hi T cells, and aging-marker fibroblasts—that mirrors patterns seen in human benign prostatic hyperplasia.

Source

Link

Briefing card

Immune dysregulation in the prostates of C57BL/6mice mirrors that seen in human benign prostatic hyperplasia.
Stage: preclinical · pubmed · 08-jul-2026

A chronic nonresolving inflammation model in C57BL/6 mice produces prostatic immune dysregulation—including Trem2 macrophages, aging-associated CD8 GZMK-hi T cells, and aging-marker fibroblasts—that mirrors patterns seen in human benign prostatic hyperplasia.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1002/path.70093

build build 880 · 2bcef25 · 2026-11-18